RAPID NEAR-PATIENT SEPSIS DIAGNOSIS
There are approximately 123,000 cases and around 46,000 associated deaths from sepsis reported in England each year, with 70% of cases coming from the community and directly costing the NHS at least 1.5bn annually.
For every hour that administration of antibiotics to septic patients is delayed, the risk of death increases by nearly 8%. Rapid near patient sepsis diagnosis is vital to aid early detection and reduce the number of associated deaths.
Following consultation with a clinical advisory and academic panel, we developed and patented a prototype for a portable microfluidic multi-assay system to be used in a range of clinical applications including early detection of sepsis.
At Medtechtomarket, we have led the development of a highly sensitive, simple and low cost microfluidic diagnostic system for the early detection and subsequent therapy monitoring of sepsis. We have demonstrated correlations with competitor laboratory systems of >0.99 on biochemical markers of sepsis.
Our in-house accredited manufacturing facility has enabled the automated pico-litre dispensing of reagents into the microfluidic device and we have utilised BioBank samples to confirm initial product applicability.
Our work in this field has seen us win two prestigious SBRI awards to support the development of the product for use in Primary care, A&E and Intensive Care.
Working in close partnership with our clients, we develop robust, compliant and commercially viable products ready for launch in the chosen market.
Point of Care Haemostasis
Working with a client based in the USA, we developed, manufactured and launched the world’s first…
Home-use Urology Monitor and Device
Medtechtomarket developed a urine collection and monitoring system for adults using indwelling catheters. Our system offered…
Medtechtomarket developed a wireless ECG device for use by professionals in primary, acute and hyper-acute care…
Rapid Near-Patient Sepsis Diagnosis
There are approximately 123,000 cases and around 46,000 associated deaths from sepsis reported in England each…
Our highly qualified team combine their expertise across a range of technologies and disciplines along with their seamlessly integrated approach to develop medical diagnostics products at our accredited facilities.
Mechanical and Solid State Systems
From ECG technologies, viscosity measurements, microscopic vision systems and mechanical techniques, Medtechtomarket has developed a number of products that deliver diagnosis with a direct measurement of the patient or on the sample itself.
Photometric and Fluorescence-Based Assays
At Medtechtomarket, we have wide-ranging experience in developing technical optical test cartridge formats and instrumentation to deliver highly sensitive colormetric, turbidity or fluorescence assay detection systems for measuring single biomarkers, enzyme assays and panels.
From state-of-the-art microfluidic immunofluorescence to traditional lateral flow technologies, we employ a range of immunological techniques to determine markers for clinical chemistry and haematology point of care diagnostic applications.
Utilising passive and active continuous-flow microfluidic approaches to channel blood and reagent samples into micro-cuvettes, flow channels, reaction chambers, electrochemistry and MEMS sensors we are able to measure a wide range of biochemical markers in a number of clinical applications.
REGISTER FOR INSIGHTS
The MedtechtoMarket team has worked together directly for over 25 years developing, producing and launching products in over 50 countries worldwide.